Dosage and administration
Adults 1-2 sprays under tongue, hold 30 seconds, 3 times a day, 5-6 days a week, at least 20 minutes before or after meals, or as directed by a physician.
Renewal HGH Advanced
- Manufacturer
- Always Young, LLC. | Apotheca Company
- Effective date
- 2024-10-02
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 20:53:22
Label at a glance#
ProductRenewal HGH Advanced
Active ingredientSELENIUM, SILICON DIOXIDE, ZINC SULFATE HEPTAHYDRATE, PHOSPHORIC ACID, SUS SCROFA PITUITARY GLAND, SULFUR, SOMATROPIN, HUMAN COLOSTRUM, HYALURONIC ACID, PREGNENOLONE, SACCHAROMYCES CEREVISIAE RNA
Label structure9 sections
Contacts and useful links#
Websitewww.alwaysyoung.com
www.AlwaysYoung.com
www.AlwaysYoung.comLabel contents#
Full prescribing information#
ACTIVE INGREDIENTS:
Selenium Metallicum 10X, Silicea 10X, Zincum Sulphuricum 10X, 30X, Phosphoricum Acidum 10X, 30C, Hypophysis Suis 10X, 30C, 100C, Sulphur 15X, 30X, Human Growth Hormone 30X, 60X, 100X, Colostrum (Human) 10C, 15C, 30C, Hyaluronic Acid 10C, 30C, 100C, Pregnenolone 10C, 30C, 100C, RNA 100C.
INDICATIONS:
To temporarily relieve symptoms related to aging; tiredness, weakness, excess fat, wrinkled skin, lack of muscle, etc.
WARNINGS:
Adults only.
If pregnant or breast-feeding, ask a health professional before use.
Cancer, heart or diabetes patients consult a physician before taking.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Do not use if tamper evident seal is broken or missing.
KEEP OUT OF REACH OF CHILDREN:
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
DIRECTIONS:
Adults 1-2 sprays under tongue, hold 30 seconds, 3 times a day, 5-6 days a week, at least 20 minutes before or after meals, or as directed by a physician.
INDICATIONS:
To temporarily relieve symptoms related to aging; tiredness, weakness, excess fat, wrinkled skin, lack of muscle, etc.
INACTIVE INGREDIENTS:
Demineralized Water, Ethanol 16%, Glycerin 8%
QUESTIONS:
PACKAGE LABEL DISPLAY:
NDC# 64631-7702-1
RENEWAL
HGH
Homeopathic
ADVANCED
1 fl oz (30 ml)
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 64631-7702-1 | 2024-10-02 | C162847 | 48780-1 | ba0f9c33-5919-a910-e053-dadaa90a0b85 | Drug Facts: |
| 64631-7702-1 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-5919-a910-e053-dadaa90a0b85 | Drug Facts: |
Products#
Every source-derived product name is available through these pages.
- Renewal HGH Advanced
- Selenium Metallicum, Silicea, Zincum Sulphuricum, Phosphoricum Acidum, Hypophysis Suis, Sulphur, Human Growth Hormone, Colostrum (Human), Hyaluronic Acid, Pregnenolone, RNA
- SELENIUM
- SILICON DIOXIDE
- ZINC SULFATE HEPTAHYDRATE
- ZINC CATION
- PHOSPHORIC ACID
- SUS SCROFA PITUITARY GLAND
- SULFUR
- SOMATROPIN
- HUMAN COLOSTRUM
- COLOSTRUM HUMAN
- HYALURONIC ACID
- PREGNENOLONE
- SACCHAROMYCES CEREVISIAE RNA
- WATER
- ALCOHOL
- GLYCERIN
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 64631-7702 | 64631-7702-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SELENIUM | H6241UJ22B | ACTIB |
| SILICON DIOXIDE | ETJ7Z6XBU4 | ACTIB |
| ZINC SULFATE HEPTAHYDRATE | N57JI2K7WP | ACTIM |
| PHOSPHORIC ACID | E4GA8884NN | ACTIB |
| SUS SCROFA PITUITARY GLAND | L0PFEMQ1DT | ACTIB |
| SULFUR | 70FD1KFU70 | ACTIB |
| SOMATROPIN | NQX9KB6PCL | ACTIB |
| HUMAN COLOSTRUM | VB6F65I6F5 | ACTIB |
| HYALURONIC ACID | S270N0TRQY | ACTIB |
| PREGNENOLONE | 73R90F7MQ8 | ACTIB |
| SACCHAROMYCES CEREVISIAE RNA | J17GBZ5VGX | ACTIB |
| WATER | 059QF0KO0R | IACT |
| ALCOHOL | 3K9958V90M | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| e304ca8b-a78c-48ee-80fe-d34a6d5cf223 | 0b0f1aaf-2865-4747-9f07-3b9610960963 | 2024-10-02 | Warnings | e304ca8b-a78c-48ee-80fe-d34a6d5cf223 0b0f1aaf-2865-4747-9f07-3b9610960963 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.